To hear about similar clinical trials, please enter your email below
Trial Title:
Endometrial Lesions Predictions
NCT ID:
NCT05588076
Condition:
Endometrial Neoplasms
Conditions: Official terms:
Endometrial Neoplasms
Study type:
Observational
Overall status:
Unknown status
Study design:
Time perspective:
Cross-Sectional
Intervention:
Intervention type:
Other
Intervention name:
no intervention
Description:
no intervention
Arm group label:
normal endometrial
Summary:
To explore the risk factors of endometrial lesions in patients with abnormal uterine
bleeding and establish prediction models which can discriminate between different
endometrial etiologies of abnormal uterine bleeding(AUB).
Criteria for eligibility:
Study pop:
This cross-sectional study was approved by the Institutional Ethics Committee and
conducted in the Beijing Friendship Hospital, Capital Medical University in China
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
-
1) non-pregnancy related abnormal uttering bleeding（AUB） in women of 18-60 years
old; 2)women who had indications for hysteroscopy and endometrial histology in
the study period
Exclusion Criteria:
-
1) postmenopausal women, 2) AUB due to other causes such as hormones or
medications, coagulation disorders, and vascular malformation of the uterus; 3)
final diagnosis outside the scope of this study.
Gender:
Female
Minimum age:
18 Years
Maximum age:
60 Years
Locations:
Facility:
Name:
Beijing Friendship Hospital
Address:
City:
Beijing
Country:
China
Start date:
October 1, 2021
Completion date:
December 1, 2022
Lead sponsor:
Agency:
Beijing Friendship Hospital
Agency class:
Other
Source:
Beijing Friendship Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05588076
